1. PARP Inhibitors in Breast Cancer: a Short Communication

   • Gordon R. Daly
   • Maen Monketh AlRawashdeh
   • Leonie Young

   ReviewPaper Open access 02 January 2024 Pages: 103 - 113

   

2. Appendiceal Neuroendocrine Neoplasms: an Update for 2023

   • Pernille Holmager
   • Seppo W. Langer
   • Ulrich Knigge

   REVIEW 02 January 2024 Pages: 114 - 120

   

3. Sarcopenia and Neuroendocrine Neoplasms

   • Dominique Clement
   • Sarah Brown
   • Rajaventhan Srirajaskanthan

   REVIEW 25 January 2024 Pages: 121 - 128

   

4. Prolymphocytic Leukaemia: an Update on Biology and Treatment

   • Dima El-Sharkawi
   • Claire Dearden

   Review 02 January 2024 Pages: 129 - 135

5. Chronic Lymphocytic Leukemia: Time-Limited Therapy in the First-Line Setting and Role of Minimal Residual Disease

   • Janina Stumpf
   • Othman Al-Sawaf

   REVIEW Open access 04 January 2024 Pages: 136 - 146

   

6. Integrative Oncology Approaches to Reduce Recurrence of Disease and Improve Survival

   • Catherine Powers-James
   • Meroë Morse
   • Lorenzo Cohen

   ReviewPaper 05 January 2024 Pages: 147 - 163

7. Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours

   • Nina Fuller-Shavel
   • Jonathan Krell

   REVIEW Open access 09 January 2024 Pages: 164 - 174

   

8. Germline Mutations and Ancestry in Prostate Cancer

   • Eudoxie Bataba
   • Kevin Babcock
   • Albert Dobi

   Review Open access 24 January 2024 Pages: 175 - 180

   

9. Elderly Rectal Cancer: An Updated Review

   • Chih-Kai Huang
   • Chi-Hsiu Shih
   • Yung-Shuo Kao

   REVIEW 25 January 2024 Pages: 181 - 190